Physician profile
Luis Alejo
NPI 1912963240
$1,260.03
in general payments reported to CMS, 2019-2025
22 companies · $481 in 2025
The $481 reported for 2025 was more than what 78% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $18.59 · 2021: $12.27 · 2022: $67.74 · 2023: $208 · 2024: $312 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $292.34 | 2024-2025 | |
| Daiichi Sankyo INC. | $125.76 | 2024 | Injectafer |
| Novartis Pharmaceuticals Corporation | $118.40 | 2019 | |
| Boston Scientific Corporation | $101.68 | 2019-2025 | Watchman Flx |
| Abbott Laboratories | $88.76 | 2022-2025 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.50 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $75.45 | 2022-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Valinor Pharma, LLC | $63.53 | 2023-2025 | Movantik |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.50 | 2024-2025 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $32.34 | 2023 | Seglentis |
| Spinal Elements, INC. | $29.61 | 2025 | |
| Lilly USA, LLC | $26.67 | 2023 | Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $23.12 | 2023 | Xarelto |
| Novo Nordisk INC | $22.53 | 2024 | Wegovy |
| Glaxosmithkline, LLC. | $21.77 | 2023 | Nucala |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $21.11 | 2023 | Prolate, Nalocet |
| Zimmer Biomet Holdings, INC. | $18.89 | 2024 | Visco-3 Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $18.62 | 2023 | Iovera, Zilretta |
| Amarin Pharma, INC. | $18.59 | 2020 | |
| Inspire Medical Systems, INC. | $16.79 | 2023 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $12.27 | 2021 | |
| Medtronic USA, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Alejo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.